| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
10 |
| Employees |
610 |
| Revenues (TTM) (Millions $) |
255 |
| Net Income (TTM) (Millions $) |
-20 |
| Cash Flow (TTM) (Millions $) |
-48 |
| Capital Exp. (TTM) (Millions $) |
6 |
Business Description
Heska Corporation is a veterinary diagnostics and specialty pharmaceuticals company.
It was founded in 1989 and is headquartered in Loveland, Colorado.
The company's mission is to enable veterinarians to provide the best possible healthcare to pets through innovative diagnostic and treatment solutions.
Heska's product portfolio includes diagnostic instruments, blood testing kits, imaging equipment, and pharmaceuticals for animal care.
These products are designed to diagnose, treat, and prevent a wide range of medical conditions in pets.
The company operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals, and Products.
The Core Companion Animal Health segment includes blood testing instruments and supplies, digital imaging systems, software solutions, allergy testing and immunotherapy, and single-use products such as needles and syringes.
The Other Vaccines, Pharmaceuticals, and Products segment includes production and sale of injectable and inhalant anesthetics, other pharmaceutical products, and vaccines for animal health, primarily targeted at production animal markets.
In recent years, Heska has expanded its international presence, with offices in Germany, France, Spain, Italy, and other countries.
The company has also made several strategic acquisitions, such as scil animal care in 2020, to enhance its diagnostic and treatment capabilities for pets.
Overall, Heska Corporation is committed to delivering innovative solutions that improve the health and quality of life of both companion and production animals.
Company Address: 3760 Rocky Mountain Avenue Loveland 80538 CO
Company Phone Number: 493-7272 Stock Exchange / Ticker: NASDAQ HSKA
|
%
1.46%